Skip to main content
  • Evolut Low-Risk Study Shows Better Long-Term Outcomes at 3 Years Post-TAVR versus SAVR

    After 3 years, patients who underwent transcatheter aortic valve replacement (TAVR) demonstrated greater benefit than those who underwent surgery with respect to all-cause mortality or disabling stroke, a new study shows.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details